Microbio Co., Ltd. (TPEX: 4128)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
35.30
+0.10 (0.28%)
Nov 15, 2024, 1:30 PM CST
-28.31%
Market Cap 21.06B
Revenue (ttm) 1.68B
Net Income (ttm) -873.89M
Shares Out 588.17M
EPS (ttm) -1.49
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 980,502
Open 35.05
Previous Close 35.20
Day's Range 35.05 - 36.00
52-Week Range 31.38 - 51.62
Beta 1.37
Analysts n/a
Price Target n/a
Earnings Date Nov 8, 2024

About Microbio

Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for ameliorating fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia and menstrual discomfort. Its pre-clinical stage products include SNA-03 and SNA-07 for cancer immune therapy; SNP-630 to treat non-alcoholic steatohepatitis; FB918 for the treatment of non-allergic eosinophilic asthma; and SNS812 for Cov-flu. The company’s Phas... [Read more]

Industry Packaged Foods
Founded 2000
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4128
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.